DV
Dividend Vision

OSRH — OSR Holdings Inc

OSR Holdings Inc (OSRH)

Total return is -96.9% over the past 3.4 years, 204.3 points behind SPY at 107.4%. Its deepest 1-year drawdown was 72.0%.

OSR Health, Inc. is a healthcare holding company developing a portfolio of immunotherapy products for oncology indications—including VXM01 for glioblastoma and several preclinical candidates targeting various tumor antigens—as well as design-augmented biologics for spinal fusion and osteoarthritis, and distributes neurovascular intervention medical devices. The company does not currently distribute dividends. OSR Health appeals to investors seeking exposure to early-stage biotech and medical device development with no current income component.

OSRH key facts

Asset type
Stock
Asset class
Equity
Inception date
03/17/2023
Last close
$0.32
Market cap
$15,358,436
Average volume
2717100.0
Beta
0.721
Payout ratio
0.0
P/E ratio
14.5833
Forward P/E
0.0
EPS
$0.03